Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1992 1
1993 1
1996 1
1997 1
1998 1
1999 3
2000 2
2001 7
2002 5
2003 5
2004 10
2005 12
2006 8
2007 8
2008 8
2009 9
2010 16
2011 5
2012 9
2013 16
2014 15
2015 15
2016 9
2017 21
2018 14
2019 18
2020 34
2021 54
2022 29
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Vougioukalos
Page 1
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI; HEP-COVID Investigators. Spyropoulos AC, et al. JAMA Intern Med. 2021 Dec 1;181(12):1612-1620. doi: 10.1001/jamainternmed.2021.6203. JAMA Intern Med. 2021. PMID: 34617959 Free PMC article. Clinical Trial.
The Veratrum and Solanum alkaloids.
Heretsch P, Giannis A. Heretsch P, et al. Alkaloids Chem Biol. 2015;74:201-32. doi: 10.1016/bs.alkal.2014.11.002. Alkaloids Chem Biol. 2015. PMID: 25845062 Review.
Pediatric surgery during the COVID-19 pandemic.
Dedeilia A, Esagian SM, Ziogas IA, Giannis D, Katsaros I, Tsoulfas G. Dedeilia A, et al. World J Clin Pediatr. 2020 Sep 19;9(2):7-16. doi: 10.5409/wjcp.v9.i2.7. eCollection 2020 Sep 19. World J Clin Pediatr. 2020. PMID: 33014718 Free PMC article. Review.
Transplant Immunosuppression Management and COVID-19.
Giannis D, Ziogas IA, Esagian SM, Matenoglou E, Moris D. Giannis D, et al. Exp Clin Transplant. 2022 Jul;20(7):706-707. doi: 10.6002/ect.2020.0179. Epub 2020 Sep 17. Exp Clin Transplant. 2022. PMID: 32967603 Free article. No abstract available.
In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d.
Bikdeli B, Garcia DA. Bikdeli B, et al. Ann Intern Med. 2022 Feb;175(2):JC17. doi: 10.7326/J21-0019. Epub 2022 Feb 1. Ann Intern Med. 2022. PMID: 35099994
Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial. ...
Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate- …
301 results